Shannon James Samuel's Form 4 filing
Xilio Therapeutics, Inc. (XLO) · filed Jun 18, 2025
- Accession no.
- 0001415889-25-017705
- Filed
- Jun 18, 2025
- Trade date
- Jun 16-17, 2025
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not checked
This filing lists 2 non-derivative transactions and 0 derivative transactions. Open-market purchases total $48.3K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Shannon James SamuelCIK 0001485417 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jun 16, 2025 | Common Stock | PPurchaseAcquired | +45,000 | $0.69 | +$31,050 | 45,000 | Direct | |
| Jun 17, 2025 | Common Stock | PPurchaseAcquired | +25,000 | $0.69 | +$17,250 | 70,000 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.